OncoMethylome Sciences Announces Licensing and Testing Agreement with Merck KGaA

OncoMethylome's Technology to Be Used in Merck's Clinical Trial Program with Cilengitide

11-Jun-2008 - OncoMethylome Sciences announced that it has signed a licensing and testing agreement with Merck KGaA of Darmstadt, Germany. Under the terms of the agreement, OncoMethylome will provide MGMT gene promoter methylation testing services for Merck's clinical trial program of cilengitide. As part of ...

OncoMethylome Sciences grants Commercial License to LabCorp for MGMT Methylation Testing

31-Mar-2008 - OncoMethylome Sciences and Laboratory Corporation of America® Holdings (LabCorp®) announced that OncoMethylome has granted LabCorp an exclusive license on certain IP technology to perform commercial MGMT methylation laboratory testing services in the United States and Canada subject to limited ...

OncoMethylome Sciences Collaborators Identify Methylation Markers that are Associated with Lung Cancer Recurrence

14-Mar-2008 - OncoMethylome Sciences announced that its research collaborators demonstrated that gene methylation is significantly associated with recurrence of early stage non-small-cell lung cancer (NSCLC). Researchers from Johns Hopkins University (JHU) and Lovelace Respiratory Research Institute ...

OncoMethylome Sciences to Profile DNA for Abbott Oncology Compounds

18-Dec-2007 - OncoMethylome Sciences entered into a pharmacogenomic service collaboration with Abbott. Under the terms of the collaboration, OncoMethylome will assist Abbott in profiling tumors. Specifically, OncoMethylome will be testing its DNA methylation biomarkers on Abbott's biological samples. "We are ...

OncoMethylome's Biomarkers Demonstrate Good Performance in Detecting Colorectal Cancer in Blood

20-Nov-2007 - OncoMethylome Sciences announced positive clinical results from its colorectal cancer screening program. Interim data from clinical trials demonstrated promising performance characteristics for OncoMethylome's blood-based colorectal cancer screening test. The new clinical trial data, which were ...

OncoMethylome Expands its Amsterdam Laboratory

Colorectal Cancer Screening Program and Service Testing Capabilities Strengthened

09-Mar-2007 - OncoMethylome Sciences announced that it has significantly expanded its Amsterdam laboratory operations. The expansion involved hiring of 10 additional scientists experienced in the field of molecular diagnostics, purchase of necessary molecular laboratory equipment, obtaining ISO laboratory ...

OncoMethylome Sciences Expands its Collaboration with Schering-Plough

26-Oct-2006 - OncoMethylome Sciences announced that it has entered into a new non-exclusive service agreement with Schering-Plough. Under the terms of the new agreement, OncoMethylome will receive processing fees for providing Schering-Plough with testing services in connection with clinical trials focused on ...